Free drug samples can change prescribing habits of US dermatologists

17 April 2014

The availability of free medication samples in dermatology offices in the USA appears to change prescribing practices for acne, a common condition for which free samples are often available, according to an article in JAMA Dermatology reported by EurekAlert. Free drug samples provided by pharmaceutical companies are widely available in dermatology practices in the USA.

The authors - Michael Hurley and colleagues from the Stanford University School of Medicine, California - investigated prescribing practices for acne vulgaris and rosacea. Data for the study were obtained from a nationally representative sample of dermatologists in the National Disease and Therapeutic Index (NDTI), a survey of office-based US physicians, and from an academic medical center where free drug samples were not available.

Branded and branded generic drugs (products that have novel dosage forms of off-patent products or use a trade name for a molecule that is off patent) accounted for 79 percent of the prescriptions written nationally by dermatologists compared with 17% at an academic medical center without samples. The average total retail cost of prescriptions at an office visit for acne was estimated to be twice as high ($465) nationally compared with about $200 at an academic medical center without samples.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical